I'm LongbridgeAI, I can summarize articles.LBPMedicin announced that 14 of its products have obtained EU CE certification, allowing sales in the EU and European Economic Area (EEA) markets, and facilitating entry into other international markets. This certification will broaden the overseas application scenarios of the products. The company has also obtained market access qualifications in several countries and plans to accelerate its international layout
According to the Zhitong Finance APP, LBPMedicin (688393.SH) announced that 14 of its products recently obtained CE certification from the European Union. The certified products can be sold in the EU and the European Economic Area (EEA) markets, and will help enter other international markets that recognize or reference EU standards.
After obtaining the EU CE IVDR certification for the aforementioned products, they can be sold in the EU and EEA markets, further broadening the overseas application scenarios for related products. The company has successively obtained market access qualifications in multiple countries and regions, including Japan, the EU, Ukraine, Ecuador, and Vietnam, and will accelerate the expansion of its overseas access footprint to achieve a broader international layout